Atlas Trials

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Clinical trial NCT03475186 · COMPLETED

Trial details

NCT number
NCT03475186
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GlioblastomaRadiotherapy; ComplicationsCognitive DeclineChemoradiation
Start date
2019-03-25
Primary completion
2025-03-25
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.